tiprankstipranks
Perspective Therapeutics to Participate at Upcoming April Investor Conferences
PremiumPress ReleasesPerspective Therapeutics to Participate at Upcoming April Investor Conferences
26d ago
Perspective Therapeutics price target raised to $1.50 from $1.20 at Oppenheimer
PremiumThe Fly
Perspective Therapeutics price target raised to $1.50 from $1.20 at Oppenheimer
1M ago
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
PremiumPress Releases
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
1M ago
Perspective Therapeutics to host analyst day
PremiumThe FlyPerspective Therapeutics to host analyst day
2M ago
Perspective Therapeutics to host analyst day
PremiumThe Fly
Perspective Therapeutics to host analyst day
2M ago
Perspective Therapeutics to host analyst day
PremiumThe Fly
Perspective Therapeutics to host analyst day
2M ago
Perspective Therapeutics Announces $87.4 Million Private Placement
PremiumPress ReleasesPerspective Therapeutics Announces $87.4 Million Private Placement
2M ago
Perspective Therapeutics sells 92M shares at 95c in private placement
PremiumThe Fly
Perspective Therapeutics sells 92M shares at 95c in private placement
2M ago
Perspective Therapeutics Inc trading halted, news pending
PremiumThe Fly
Perspective Therapeutics Inc trading halted, news pending
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100